Boundless Bio, Inc. Share Price: BOLD (Boundless Bio, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Boundless Bio, Inc. share price today?

Accepted Answer

Boundless Bio, Inc. (BOLD) share price today is {{live_price}}.

Question 2

Can Indians buy Boundless Bio, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Boundless Bio, Inc. (BOLD) from India.

With INDmoney, you can buy Boundless Bio, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Boundless Bio, Inc. at zero transaction cost.

Question 3

How can I buy Boundless Bio, Inc. shares from India?

Accepted Answer

It is very easy to buy Boundless Bio, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Boundless Bio, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Boundless Bio, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Boundless Bio, Inc. stocks?

Accepted Answer

To start investing in Boundless Bio, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Boundless Bio, Inc.

Accepted Answer

Today’s highest price of Boundless Bio, Inc. (BOLD) is {{1_rba_end}}.

Today’s lowest price of Boundless Bio, Inc. (BOLD) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Boundless Bio, Inc.

Accepted Answer

Today's market capitalisation of Boundless Bio, Inc. BOLD is 71.4M

Question 8

What is the 52 Week High and Low Range of Boundless Bio, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Boundless Bio, Inc. is down from its 52 Week High?

Accepted Answer

Boundless Bio, Inc. (BOLD) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Boundless Bio, Inc. is up from its 52 Week low?

Accepted Answer

Boundless Bio, Inc. (BOLD) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Boundless Bio, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Boundless Bio, Inc.

Accepted Answer

Dr. Jonathan E. Lim M.D. is the current Chief Executive Officer (CEO) of Boundless Bio, Inc..

Period	Boundless Bio, Inc.	Index (Russel 2000)
3 Months	-67.46%	0.0%
6 Months	-78.04%	0.0%
1 Year	-78.04%	0.0%
3 Years	-78.04%	-22.3%

Market Capitalization	71.4M
Book Value	- $111.86
Earnings Per Share (EPS)	-2.39
Wall Street Target Price	23.0

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-33.13%
Return On Equity TTM	-61.55%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-58.6M
Diluted Eps TTM	-2.39
Quarterly Earnings Growth YOY	0.0

Boundless Bio, Inc. (BOLD)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Company Information

Discover More

FAQs

EPS Estimate Current Year	-6.76
EPS Estimate Next Year	-4.59
EPS Estimate Current Quarter	0.0
EPS Estimate Next Quarter	0.0

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Boundless Bio, Inc.	-5.15%	-78.04%	-78.04%	-78.04%	-89.78%
Regeneron Pharmaceuticals, Inc.	5.97%	16.25%	37.11%	69.18%	305.56%
Novo Nordisk A/s	9.99%	-3.52%	34.24%	158.74%	417.73%
Alnylam Pharmaceuticals, Inc.	-5.15%	64.67%	22.72%	31.08%	198.44%
Vertex Pharmaceuticals Incorporated	0.45%	14.0%	36.06%	143.5%	167.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Boundless Bio, Inc.	NA	NA	NA	-6.76	-0.62	-0.33	NA	-111.86
Regeneron Pharmaceuticals, Inc.	29.93	29.93	1.54	45.05	0.17	0.08	NA	261.41
Novo Nordisk A/s	44.01	44.01	1.98	3.44	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.55	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.57	0.32	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Boundless Bio, Inc.	NA	$71.4M	-89.78%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$124.7B	305.56%	29.93	32.04%
Novo Nordisk A/s	Buy	$585.3B	417.73%	44.01	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$32.3B	198.44%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$120.9B	167.72%	32.84	-4.74%

Organization	Boundless Bio, Inc.
Employees	72
CEO	Dr. Jonathan E. Lim M.D.
Industry	Health Technology